← Back to directory
Scott S. Tykodi
Researcher Next ID · RN-009003
Researcher · Medicine
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Cape Town, South Africa
Not currently recruitingFunding unknown
- Works count
- 227
- Citation count
- 21,484
- H-index
- 40
- i10-index
- 86
Research interests
Medicine
Biochemistry, Genetics and Molecular Biology
Renal cell carcinoma treatment
Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
Renal and related cancers
Cancer Genomics and Diagnostics
Publications
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial
The Lancet Oncology · 2019 · https://doi.org/10.1016/s1470-2045(19)30413-9
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1510665
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1200694
Current projects
No projects listed.